MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Income Overview

Revenue
$104K
Net Income
-$9,238K
Net Profit Margin
-8882.69%
EPS
-$0.14
Unit: Thousand (K) dollars
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Royalty revenues
104
41
243
120
Research and development
5,915
6,765
5,075
8,197
Selling, general and administrative
3,804
6,126
2,995
3,897
Total operating expenses
9,719
12,891
8,070
12,094
Loss from operations
-9,615
-12,850
-7,827
-11,974
Interest income
382
506
612
716
Other income (expense), net
1
-1
-1
0
Total other income (expense), net
383
505
611
716
Net loss
-9,232
-12,345
-7,216
-11,258
Preferred stock dividend payable on series a convertible preferred stock
6
6
7
6
Net loss attributable to common stockholders
-9,238
-12,351
-7,223
-11,264
Basic EPS
-0.14
-0.18
-0.107
-0.17
Diluted EPS
-0.14
-0.18
-0.107
-0.17
Basic Average Shares
68,397,000
68,350,000
67,435,000
66,879,000
Diluted Average Shares
68,397,000
68,350,000
67,435,000
66,879,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

CRDF Income Statement Sankey DiagramSankey diagram visualizing CRDF income statement for the periodNet lossattributable to common...-$9,238K (33.77%↑ Y/Y)Interest income$382K (-54.25%↓ Y/Y)Other income(expense), net$1K (200.00%↑ Y/Y)Net loss-$9,232K (33.79%↑ Y/Y)Preferred stock dividendpayable on series a...$6K (0.00%↑ Y/Y)Total other income(expense), net$383K (-54.08%↓ Y/Y)Loss from operations-$9,615K (34.93%↑ Y/Y)Royalty revenues$104K (-14.05%↓ Y/Y)Total operatingexpenses$9,719K (-34.76%↓ Y/Y)Research and development$5,915K (-48.92%↓ Y/Y)Selling, general andadministrative$3,804K (14.65%↑ Y/Y)

Cardiff Oncology, Inc. (CRDF)

Cardiff Oncology, Inc. (CRDF)